PBYI
NASDAQ · Biotechnology
Puma Biotechnology Inc
$6.19
-0.06 (-0.96%)
Open$6.17
Previous Close$6.25
Day High$6.30
Day Low$6.10
52W High$7.68
52W Low$2.58
Volume—
Avg Volume660.5K
Market Cap316.96M
P/E Ratio8.57
EPS$0.74
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
-12.0% upside
Current
$6.19
$6.19
Target
$5.45
$5.45
$2.99
$5.45 avg
$6.80
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 218.79M | 225.76M | 42.11M |
| Net Income | 28.75M | 26.70M | 7.89M |
| Profit Margin | 13.1% | 12.5% | 18.7% |
| EBITDA | 41.15M | 40.34M | 13.15M |
| Free Cash Flow | — | — | 4.76M |
| Rev Growth | -3.1% | -3.1% | +7.6% |
| Debt/Equity | 0.73 | 0.73 | 0.46 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |